Boundless Bio Stock Quote BOLD - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

2.73

Bid

2.56

Ask

2.83

Volume

0.00 Day's Range 0.00

2.33 52 Week Range 59.97

Market Cap

60.879M

Previous Close

2.73

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

77,090

Shares Outstanding

22,300,043

Dividend Yield

PE Ratio

-1.23

Earnings Per Share (EPS)

-2.22

Revenue

Net Profit

-49.43M

Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical t... Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.boundlessbio.com

Headquarters

Wilmington, Delaware, USA

Founded

Boundless Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BOLD. The last closing price for Boundless Bio was $2.73. Over the last year, Boundless Bio shares have traded in a share price range of $ 2.33 to $ 59.97.

Boundless Bio currently has 22,300,043 shares outstanding. The market capitalization of Boundless Bio is $60.88 million. Boundless Bio has a price to earnings ratio (PE ratio) of -1.23.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.3	12.3456790123	2.43	2.89	2.41	108867	2.60989264	CS
4	-0.28	-9.3023255814	3.01	3.75	2.33	107111	2.77628166	CS
12	-0.43	-13.6075949367	3.16	4.72	2.33	77090	3.08192145	CS
26	-6.04	-68.8711516534	8.77	10.13	2.33	81619	3.92419526	CS
52	-57.24	-95.4477238619	59.97	59.97	2.33	70193	7.15935326	CS
156	-57.24	-95.4477238619	59.97	59.97	2.33	23243	7.15935326	CS
260	-26.78	-90.7488986784	29.51	60	2.33	81278	48.76862002	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SNTISenti Biosciences Inc	$ 5.87 (171.76%)	20.55M
JCSEJE Cleantech Holdings Limited	$ 1.95 (63.87%)	7.23M
PPBTPurple Biotech Ltd	$ 5.41 (61.25%)	9.47M
UPBUpstream Bio Inc	$ 34.77 (58.98%)	40
SGBXSafe and Green Holdings Corporation	$ 0.7589 (54.88%)	29.52M
LGHLWLion Group Holding Ltd	$ 0.0061 (-31.46%)	530
CWBCCommunity West Bancshares New	$ 17.01 (-22.40%)	8
TTGTTech Target Inc	$ 25.01 (-22.11%)	5
BOTJBank of the James Financial Group Inc	$ 12.01 (-22.06%)	1
MDCXMedicus Pharma Ltd	$ 2.10 (-21.64%)	295
SGBXSafe and Green Holdings Corporation	$ 0.7548 (54.04%)	29.52M
RGTIRigetti Computing Inc	$ 3.4299 (12.46%)	22.08M
SNTISenti Biosciences Inc	$ 5.91 (173.61%)	20.57M
PRZOParaZero Technologies Ltd	$ 1.61 (29.84%)	15.25M
XTIAXTI Aerospace Inc	$ 0.0509 (13.36%)	13.3M